 | • レポートコード：MRC2Q12-19131 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、76ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、乳児＆幼児用風邪薬のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 乳児＆幼児用風邪薬のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 乳児＆幼児用風邪薬の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 乳児＆幼児用風邪薬のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの乳児＆幼児用風邪薬の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の乳児＆幼児用風邪薬の売上および2028年までの予測に焦点を当てています。 乳児＆幼児用風邪薬のグローバル主要企業には、Hyland's Inc、Perrigo、Taro Pharmaceuticals USA, Inc.、Intas Pharmaceuticals Ltdなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 乳児＆幼児用風邪薬市場は、タイプとアプリケーションによって区分されます。世界の乳児＆幼児用風邪薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 経口薬、直腸坐剤 【アプリケーション別セグメント】 オンライン販売、薬局販売 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 乳児＆幼児用風邪薬製品概要 - タイプ別市場（経口薬、直腸坐剤） - アプリケーション別市場（オンライン販売、薬局販売） - 調査の目的 ・エグゼクティブサマリー - 世界の乳児＆幼児用風邪薬販売量予測2017-2028 - 世界の乳児＆幼児用風邪薬売上予測2017-2028 - 乳児＆幼児用風邪薬の地域別販売量 - 乳児＆幼児用風邪薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別乳児＆幼児用風邪薬販売量 - 主要メーカー別乳児＆幼児用風邪薬売上 - 主要メーカー別乳児＆幼児用風邪薬価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（経口薬、直腸坐剤） - 乳児＆幼児用風邪薬のタイプ別販売量 - 乳児＆幼児用風邪薬のタイプ別売上 - 乳児＆幼児用風邪薬のタイプ別価格 ・アプリケーション別市場規模（オンライン販売、薬局販売） - 乳児＆幼児用風邪薬のアプリケーション別販売量 - 乳児＆幼児用風邪薬のアプリケーション別売上 - 乳児＆幼児用風邪薬のアプリケーション別価格 ・北米市場 - 北米の乳児＆幼児用風邪薬市場規模（タイプ別、アプリケーション別） - 主要国別の乳児＆幼児用風邪薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの乳児＆幼児用風邪薬市場規模（タイプ別、アプリケーション別） - 主要国別の乳児＆幼児用風邪薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の乳児＆幼児用風邪薬市場規模（タイプ別、アプリケーション別） - 主要国別の乳児＆幼児用風邪薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の乳児＆幼児用風邪薬市場規模（タイプ別、アプリケーション別） - 主要国別の乳児＆幼児用風邪薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの乳児＆幼児用風邪薬市場規模（タイプ別、アプリケーション別） - 主要国別の乳児＆幼児用風邪薬市場規模（トルコ、サウジアラビア） ・企業情報 Hyland's Inc、Perrigo、Taro Pharmaceuticals USA, Inc.、Intas Pharmaceuticals Ltd ・産業チェーン及び販売チャネル分析 - 乳児＆幼児用風邪薬の産業チェーン分析 - 乳児＆幼児用風邪薬の原材料 - 乳児＆幼児用風邪薬の生産プロセス - 乳児＆幼児用風邪薬の販売及びマーケティング - 乳児＆幼児用風邪薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 乳児＆幼児用風邪薬の産業動向 - 乳児＆幼児用風邪薬のマーケットドライバー - 乳児＆幼児用風邪薬の課題 - 乳児＆幼児用風邪薬の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Infant and Baby Cold Medicine Market
Due to the COVID-19 pandemic, the global Infant and Baby Cold Medicine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Oral Medication accounting for % of the Infant and Baby Cold Medicine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Online Sales segment is altered to an % CAGR throughout this forecast period.
China Infant and Baby Cold Medicine market size is valued at US$ million in 2021, while the US and Europe Infant and Baby Cold Medicine are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Infant and Baby Cold Medicine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Infant and Baby Cold Medicine include Hyland’s Inc, Perrigo, Taro Pharmaceuticals USA, Inc. and Intas Pharmaceuticals Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Infant and Baby Cold Medicine Scope and Segment
Infant and Baby Cold Medicine market is segmented by Type and by Distribution Channel. Players, stakeholders, and other participants in the global Infant and Baby Cold Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Distribution Channel for the period 2017-2028.
Segment by Type
Oral Medication
Rectal Suppositories
Segment by Distribution Channel
Online Sales
Drugstore Sales
By Company
Hyland’s Inc
Perrigo
Taro Pharmaceuticals USA, Inc.
Intas Pharmaceuticals Ltd
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Infant and Baby Cold Medicine Product Introduction
1.2 Market by Type
1.2.1 Global Infant and Baby Cold Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral Medication
1.2.3 Rectal Suppositories
1.3 Market by Distribution Channel
1.3.1 Global Infant and Baby Cold Medicine Market Size Growth Rate by Distribution Channel, 2017 VS 2021 VS 2028
1.3.2 Online Sales
1.3.3 Drugstore Sales
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Infant and Baby Cold Medicine Sales Estimates and Forecasts 2017-2028
2.2 Global Infant and Baby Cold Medicine Revenue Estimates and Forecasts 2017-2028
2.3 Global Infant and Baby Cold Medicine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Infant and Baby Cold Medicine Sales by Region
2.4.1 Global Infant and Baby Cold Medicine Sales by Region (2017-2022)
2.4.2 Global Sales Infant and Baby Cold Medicine by Region (2023-2028)
2.5 Global Infant and Baby Cold Medicine Revenue by Region
2.5.1 Global Infant and Baby Cold Medicine Revenue by Region (2017-2022)
2.5.2 Global Infant and Baby Cold Medicine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Infant and Baby Cold Medicine Sales by Manufacturers
3.1.1 Global Top Infant and Baby Cold Medicine Manufacturers by Sales (2017-2022)
3.1.2 Global Infant and Baby Cold Medicine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Infant and Baby Cold Medicine in 2021
3.2 Global Infant and Baby Cold Medicine Revenue by Manufacturers
3.2.1 Global Infant and Baby Cold Medicine Revenue by Manufacturers (2017-2022)
3.2.2 Global Infant and Baby Cold Medicine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Infant and Baby Cold Medicine Revenue in 2021
3.3 Global Infant and Baby Cold Medicine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Infant and Baby Cold Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Infant and Baby Cold Medicine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Infant and Baby Cold Medicine Sales by Type
4.1.1 Global Infant and Baby Cold Medicine Historical Sales by Type (2017-2022)
4.1.2 Global Infant and Baby Cold Medicine Forecasted Sales by Type (2023-2028)
4.1.3 Global Infant and Baby Cold Medicine Sales Market Share by Type (2017-2028)
4.2 Global Infant and Baby Cold Medicine Revenue by Type
4.2.1 Global Infant and Baby Cold Medicine Historical Revenue by Type (2017-2022)
4.2.2 Global Infant and Baby Cold Medicine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Infant and Baby Cold Medicine Revenue Market Share by Type (2017-2028)
4.3 Global Infant and Baby Cold Medicine Price by Type
4.3.1 Global Infant and Baby Cold Medicine Price by Type (2017-2022)
4.3.2 Global Infant and Baby Cold Medicine Price Forecast by Type (2023-2028)
5 Market Size by Distribution Channel
5.1 Global Infant and Baby Cold Medicine Sales by Distribution Channel
5.1.1 Global Infant and Baby Cold Medicine Historical Sales by Distribution Channel (2017-2022)
5.1.2 Global Infant and Baby Cold Medicine Forecasted Sales by Distribution Channel (2023-2028)
5.1.3 Global Infant and Baby Cold Medicine Sales Market Share by Distribution Channel (2017-2028)
5.2 Global Infant and Baby Cold Medicine Revenue by Distribution Channel
5.2.1 Global Infant and Baby Cold Medicine Historical Revenue by Distribution Channel (2017-2022)
5.2.2 Global Infant and Baby Cold Medicine Forecasted Revenue by Distribution Channel (2023-2028)
5.2.3 Global Infant and Baby Cold Medicine Revenue Market Share by Distribution Channel (2017-2028)
5.3 Global Infant and Baby Cold Medicine Price by Distribution Channel
5.3.1 Global Infant and Baby Cold Medicine Price by Distribution Channel (2017-2022)
5.3.2 Global Infant and Baby Cold Medicine Price Forecast by Distribution Channel (2023-2028)
6 North America
6.1 North America Infant and Baby Cold Medicine Market Size by Type
6.1.1 North America Infant and Baby Cold Medicine Sales by Type (2017-2028)
6.1.2 North America Infant and Baby Cold Medicine Revenue by Type (2017-2028)
6.2 North America Infant and Baby Cold Medicine Market Size by Distribution Channel
6.2.1 North America Infant and Baby Cold Medicine Sales by Distribution Channel (2017-2028)
6.2.2 North America Infant and Baby Cold Medicine Revenue by Distribution Channel (2017-2028)
6.3 North America Infant and Baby Cold Medicine Market Size by Country
6.3.1 North America Infant and Baby Cold Medicine Sales by Country (2017-2028)
6.3.2 North America Infant and Baby Cold Medicine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Infant and Baby Cold Medicine Market Size by Type
7.1.1 Europe Infant and Baby Cold Medicine Sales by Type (2017-2028)
7.1.2 Europe Infant and Baby Cold Medicine Revenue by Type (2017-2028)
7.2 Europe Infant and Baby Cold Medicine Market Size by Distribution Channel
7.2.1 Europe Infant and Baby Cold Medicine Sales by Distribution Channel (2017-2028)
7.2.2 Europe Infant and Baby Cold Medicine Revenue by Distribution Channel (2017-2028)
7.3 Europe Infant and Baby Cold Medicine Market Size by Country
7.3.1 Europe Infant and Baby Cold Medicine Sales by Country (2017-2028)
7.3.2 Europe Infant and Baby Cold Medicine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Infant and Baby Cold Medicine Market Size by Type
8.1.1 Asia Pacific Infant and Baby Cold Medicine Sales by Type (2017-2028)
8.1.2 Asia Pacific Infant and Baby Cold Medicine Revenue by Type (2017-2028)
8.2 Asia Pacific Infant and Baby Cold Medicine Market Size by Distribution Channel
8.2.1 Asia Pacific Infant and Baby Cold Medicine Sales by Distribution Channel (2017-2028)
8.2.2 Asia Pacific Infant and Baby Cold Medicine Revenue by Distribution Channel (2017-2028)
8.3 Asia Pacific Infant and Baby Cold Medicine Market Size by Region
8.3.1 Asia Pacific Infant and Baby Cold Medicine Sales by Region (2017-2028)
8.3.2 Asia Pacific Infant and Baby Cold Medicine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Infant and Baby Cold Medicine Market Size by Type
9.1.1 Latin America Infant and Baby Cold Medicine Sales by Type (2017-2028)
9.1.2 Latin America Infant and Baby Cold Medicine Revenue by Type (2017-2028)
9.2 Latin America Infant and Baby Cold Medicine Market Size by Distribution Channel
9.2.1 Latin America Infant and Baby Cold Medicine Sales by Distribution Channel (2017-2028)
9.2.2 Latin America Infant and Baby Cold Medicine Revenue by Distribution Channel (2017-2028)
9.3 Latin America Infant and Baby Cold Medicine Market Size by Country
9.3.1 Latin America Infant and Baby Cold Medicine Sales by Country (2017-2028)
9.3.2 Latin America Infant and Baby Cold Medicine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Infant and Baby Cold Medicine Market Size by Type
10.1.1 Middle East and Africa Infant and Baby Cold Medicine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Infant and Baby Cold Medicine Revenue by Type (2017-2028)
10.2 Middle East and Africa Infant and Baby Cold Medicine Market Size by Distribution Channel
10.2.1 Middle East and Africa Infant and Baby Cold Medicine Sales by Distribution Channel (2017-2028)
10.2.2 Middle East and Africa Infant and Baby Cold Medicine Revenue by Distribution Channel (2017-2028)
10.3 Middle East and Africa Infant and Baby Cold Medicine Market Size by Country
10.3.1 Middle East and Africa Infant and Baby Cold Medicine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Infant and Baby Cold Medicine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Hyland’s Inc
11.1.1 Hyland’s Inc Corporation Information
11.1.2 Hyland’s Inc Overview
11.1.3 Hyland’s Inc Infant and Baby Cold Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Hyland’s Inc Infant and Baby Cold Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Hyland’s Inc Recent Developments
11.2 Perrigo
11.2.1 Perrigo Corporation Information
11.2.2 Perrigo Overview
11.2.3 Perrigo Infant and Baby Cold Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Perrigo Infant and Baby Cold Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Perrigo Recent Developments
11.3 Taro Pharmaceuticals USA, Inc.
11.3.1 Taro Pharmaceuticals USA, Inc. Corporation Information
11.3.2 Taro Pharmaceuticals USA, Inc. Overview
11.3.3 Taro Pharmaceuticals USA, Inc. Infant and Baby Cold Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Taro Pharmaceuticals USA, Inc. Infant and Baby Cold Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Taro Pharmaceuticals USA, Inc. Recent Developments
11.4 Intas Pharmaceuticals Ltd
11.4.1 Intas Pharmaceuticals Ltd Corporation Information
11.4.2 Intas Pharmaceuticals Ltd Overview
11.4.3 Intas Pharmaceuticals Ltd Infant and Baby Cold Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Intas Pharmaceuticals Ltd Infant and Baby Cold Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Intas Pharmaceuticals Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Infant and Baby Cold Medicine Industry Chain Analysis
12.2 Infant and Baby Cold Medicine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Infant and Baby Cold Medicine Production Mode & Process
12.4 Infant and Baby Cold Medicine Sales and Marketing
12.4.1 Infant and Baby Cold Medicine Sales Channels
12.4.2 Infant and Baby Cold Medicine Distributors
12.5 Infant and Baby Cold Medicine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Infant and Baby Cold Medicine Industry Trends
13.2 Infant and Baby Cold Medicine Market Drivers
13.3 Infant and Baby Cold Medicine Market Challenges
13.4 Infant and Baby Cold Medicine Market Restraints
14 Key Findings in The Global Infant and Baby Cold Medicine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer